ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,731Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 939

$694K Total Retail Price of All Prescriptions

Rank: 132 out of 939

426 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 426 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 426 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 12,158 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
GABAPENTIN 656 500 1 11
LEVOTHYROXINE SODIUM 488 368 2 4
AMLODIPINE BESYLATE 471 388 3 6
OMEPRAZOLE 449 309 4 5
FUROSEMIDE 440 391 5 7
POTASSIUM CHLORIDE 420 359 6 9
CITALOPRAM HBR 392 284 7 15
LISINOPRIL 376 271 8 3
HYDROCODONE-ACETAMINOPHEN 368 219 S3 9 1
METFORMIN HCL 353 219 10 8
SIMVASTATIN 302 245 11 2
SUCRALFATE 298 208 12 96
HYDROCHLOROTHIAZIDE 293 190 13 12
TRAZODONE HCL 254 153 14 26
NEXIUM 240 175 15 18
MIRTAZAPINE 217 151 16 56
PRAVASTATIN SODIUM 214 123 17 13
RANITIDINE HCL 210 161 18 35
MEGESTROL ACETATE 195 180 R 19 136
LABETALOL HCL 194 165 20 198
SERTRALINE HCL 187 123 21 24
WARFARIN SODIUM 186 184 22 17
QUETIAPINE FUMARATE 180 109 23 69
DONEPEZIL HCL 178 164 24 30
METOPROLOL TARTRATE 177 126 25 10
DOXYCYCLINE HYCLATE 169 128 26 84
METOPROLOL SUCCINATE 166 133 27 21
ATENOLOL 166 117 27 19
GLIPIZIDE 164 112 29 52
ZOLPIDEM TARTRATE 156 110 30 20
TRAMADOL HCL 153 106 31 16
DEXAMETHASONE SODIUM PHOSPHATE 145 131 32 305
SPIRONOLACTONE 137 128 33 71
POLYETHYLENE GLYCOL 3350 136 103 34 57
CIPROFLOXACIN HCL 133 96 35 54
SULFAMETHOXAZOLE-TRIMETHOPRIM 121 84 36 64
ALLOPURINOL 118 95 37 31
NAMENDA 116 115 38 49
LOSARTAN POTASSIUM 113 95 39 29
FLUOXETINE HCL 112 33 40 47
CEFTRIAXONE 112 92 40 197
CARAFATE 111 103 42 209
GENTAMICIN SULFATE 111 96 42 237
TAMSULOSIN HCL 107 85 44 27
FAMOTIDINE 105 82 45 62
PLAVIX 97 77 46 48
CLOPIDOGREL 93 61 47 28
LOVASTATIN 92 65 48 46
METOCLOPRAMIDE HCL 88 66 49 119
SEROQUEL 88 59 49 139
FENTANYL 87 51 S2 51 104
DILTIAZEM ER 85 70 52 94
DIGOXIN 84 81 53 45
DIOVAN 82 77 54 50
TRIAMTERENE-HCTZ 79 57 55 33
CARVEDILOL 76 73 56 25
ALENDRONATE SODIUM 74 73 57 40
NITROFURANTOIN MONO-MACRO 72 67 58 180
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 37 58 23
RISPERIDONE 71 36 60 82
ATORVASTATIN CALCIUM 71 57 60 22
ESTRADIOL 69 29 R 62 79
GLYBURIDE 67 50 R 63 89
CEFUROXIME 66 49 64 166
OXYBUTYNIN CHLORIDE 65 52 65 125
PANTOPRAZOLE SODIUM 64 40 66 66
CARBIDOPA-LEVODOPA 63 63 67 102
FLUDROCORTISONE ACETATE 62 50 68 315
AMITRIPTYLINE HCL 61 24 R 69 38
LANTUS 61 60 69 59
VENLAFAXINE HCL 60 41 71 159
CYMBALTA 56 16 72 44
LANSOPRAZOLE 55 14 73 177
ACTOS 54 42 74 141
OLANZAPINE 54 0 74 135
PROMETHAZINE HCL 53 33 R 76 68
LEVOFLOXACIN 52 38 77 86
DOXAZOSIN MESYLATE 52 52 77 108
CEPHALEXIN 51 35 79 77
ACETAMINOPHEN-CODEINE 51 42 S3 79 116
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.